This company has been acquired
Silk Road Medical Balance Sheet Health
Financial Health criteria checks 6/6
Silk Road Medical has a total shareholder equity of $154.7M and total debt of $76.1M, which brings its debt-to-equity ratio to 49.2%. Its total assets and total liabilities are $269.8M and $115.1M respectively.
Key information
49.2%
Debt to equity ratio
US$76.15m
Debt
Interest coverage ratio | n/a |
Cash | US$171.98m |
Equity | US$154.68m |
Total liabilities | US$115.12m |
Total assets | US$269.81m |
Recent financial health updates
Is Silk Road Medical (NASDAQ:SILK) A Risky Investment?
May 02Is Silk Road Medical (NASDAQ:SILK) Weighed On By Its Debt Load?
Nov 03Is Silk Road Medical (NASDAQ:SILK) A Risky Investment?
Aug 05Is Silk Road Medical (NASDAQ:SILK) A Risky Investment?
Apr 04Is Silk Road Medical (NASDAQ:SILK) Using Too Much Debt?
Sep 24Recent updates
Silk Road Medical, Inc (NASDAQ:SILK) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
May 03Is Silk Road Medical (NASDAQ:SILK) A Risky Investment?
May 02Silk Road Medical, Inc's (NASDAQ:SILK) Shares Leap 35% Yet They're Still Not Telling The Full Story
Feb 03A Piece Of The Puzzle Missing From Silk Road Medical, Inc's (NASDAQ:SILK) 26% Share Price Climb
Dec 20Is Silk Road Medical (NASDAQ:SILK) Weighed On By Its Debt Load?
Nov 03Is Silk Road Medical (NASDAQ:SILK) A Risky Investment?
Aug 05Shareholders Should Be Pleased With Silk Road Medical, Inc's (NASDAQ:SILK) Price
May 05Is Silk Road Medical (NASDAQ:SILK) A Risky Investment?
Apr 04Silk Road Medical announces $100M common stock offering
Oct 17Is Silk Road Medical (NASDAQ:SILK) Using Too Much Debt?
Sep 24Silk Road Medical GAAP EPS of -$0.44 beats by $0.02, revenue of $33.17M beats by $2.14M
Jul 26Silk Road Medical: Divergence From Alternative Risk Premia Means Lack Of Upside Capture
Jul 19Financial Position Analysis
Short Term Liabilities: SILK's short term assets ($241.0M) exceed its short term liabilities ($31.6M).
Long Term Liabilities: SILK's short term assets ($241.0M) exceed its long term liabilities ($83.6M).
Debt to Equity History and Analysis
Debt Level: SILK has more cash than its total debt.
Reducing Debt: SILK's debt to equity ratio has reduced from 53% to 49.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: SILK has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: SILK has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 3.4% each year
Discover healthy companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/09/16 21:15 |
End of Day Share Price | 2024/09/16 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Silk Road Medical, Inc is covered by 9 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
null null | Argus Research Company |
Joanne Wuensch | BMO Capital Markets Equity Research |
Travis Steed | BofA Global Research |